🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
68.55
-0.58 (-0.84%)
At close: Nov 20, 2026, 4:00 PM EST
68.90
+0.35 (0.51%)
After-hours: Nov 20, 2026, 7:39 PM EST

ANI Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,041883.37614.38486.82316.39216.14
Revenue Growth
25.94%43.78%26.20%53.87%46.38%3.67%
Cost of Revenue
405.54341.31236.61181.51138.79100.61
Gross Profit
635.8542.06377.77305.3177.6115.53
Selling, General & Admin
349.87315.65231.54161.7124.0484.29
Research & Development
50.6151.6644.5834.2922.3211.37
Other Operating Expenses
-----0.78
Operating Expenses
483.2458.73343.85255.77203.33143.7
Operating Income
152.6183.3333.9249.53-25.73-28.17
Interest Expense
-30.21-32.18-33.14-35.05-28.42-11.95
Interest & Investment Income
15.3412.1215.538.110.370.02
Currency Exchange Gain (Loss)
-0.511.93----
Other Non Operating Income (Expenses)
---4.03-0.160.67-4.71
EBT Excluding Unusual Items
137.2265.212.2822.43-53.12-44.8
Merger & Restructuring Charges
-2.1-2.1-31.7-1.13-5.68-
Gain (Loss) on Sale of Investments
6.732.826.31---
Gain (Loss) on Sale of Assets
-0.09-0.385.35--1.82
Asset Writedown
--0.77-7.6--0.11-2.37
Legal Settlements
9-----8.75
Other Unusual Items
7.0731.01-6.85-1.43-3.76-1.96
Pretax Income
157.8495.79-22.2119.87-62.67-56.06
Income Tax Expense
4117.45-3.691.09-14.77-13.46
Net Income
116.8478.34-18.5218.78-47.9-42.6
Preferred Dividends & Other Adjustments
8.318.121.633.31.630.19
Net Income to Common
108.5370.22-20.1515.48-49.52-42.79
Net Income Growth
217.82%-----
Shares Outstanding (Basic)
212019181613
Shares Outstanding (Diluted)
222119181613
Shares Change
5.83%9.89%6.18%11.89%29.09%5.28%
EPS (Basic)
5.173.50-1.040.86-3.05-3.40
EPS (Diluted)
5.003.32-1.040.85-3.05-3.40
EPS Growth
198.73%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
205.32171.3947.78110.09-40.080.77
Free Cash Flow Per Share
9.448.072.476.05-2.460.06
Gross Margin
61.06%61.36%61.49%62.71%56.13%53.45%
Operating Margin
14.66%9.43%5.52%10.17%-8.13%-13.03%
Profit Margin
10.42%7.95%-3.28%3.18%-15.65%-19.80%
Free Cash Flow Margin
19.72%19.40%7.78%22.61%-12.67%0.35%
EBITDA
235.33174.75101.65109.3233.9219.08
EBITDA Margin
22.60%19.78%16.55%22.46%10.72%8.83%
D&A For EBITDA
82.7291.4267.7359.7959.6547.25
EBIT
152.6183.3333.9249.53-25.73-28.17
EBIT Margin
14.66%9.43%5.52%10.17%-8.13%-13.03%
Effective Tax Rate
25.97%18.22%-5.50%--
SEC Filings: 10-K · 10-Q